Inside GSK-Medicago COVID-19 deal: A relative to tobacco is key to vaccine
An ancient relative of tobacco is at the heart of a new COVID-19 vaccine under development by Medicago and GSK. Here’s a look at what’s happening.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
